Bharat Biotech MD Krishna Ella also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, which is now undergoing phase 3 trials.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.